Aptahem announces strengthened research results with Apta-1 from completed NHP study

Aptahem (publ) today announce positive final results from the exploratory sepsis study with non human primates, the NHP study. The new preclinical results continue to support Apta-1’s multifunctional drug candidate potential within the treatment of sepsis. The completed comprehensive...

Read More

Aptahem present preclinical progress of the company’s lead candidate Apta-1 at the world’s largest conference for intensive care

Aptahem (publ) announced today that a presentation entitled “Apta-1, a novel RNA aptamer, improves outcome in an animal model of sepsis” will be held at the World Congress of Intensive Care in Melbourne, Australia, October 14-18, 2019. This conference...

Read More